ID
32734
Description
Study ID: 109059 Clinical Study ID: OTB109059 Study Title: TXA107979:A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01021553 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: epelsiban Trade Name: Study Indication: Premature Ejaculation
Mots-clés
Versions (1)
- 13/11/2018 13/11/2018 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
13 novembre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Delay in IELT, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK557296 in Men with Premature Ejaculation, 109059
IP Compliance
- StudyEvent: ODM
Description
IP Compliance Dispensed
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
- UMLS CUI-3
- C1880359
Description
Experimental Drug, Dispense, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C0011008
Description
Experimental Drug, Blister Pack, First, Number
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1706080
- UMLS CUI [1,3]
- C0205435
- UMLS CUI [1,4]
- C0237753
Description
Experimental Drug, Dispense, Blister Pack, First, Count of entities
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C1706080
- UMLS CUI [1,4]
- C0205435
- UMLS CUI [1,5]
- C0449788
Description
Experimental Drug, Blister Pack, Second, Number
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1706080
- UMLS CUI [1,3]
- C0205436
- UMLS CUI [1,4]
- C0237753
Description
Experimental Drug, Dispense, Blister Pack, Second, Count of entities
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C1706080
- UMLS CUI [1,4]
- C0205436
- UMLS CUI [1,5]
- C0449788
Similar models
IP Compliance
- StudyEvent: ODM
C1321605 (UMLS CUI-2)
C0332156 (UMLS CUI-3)
C0332156 (UMLS CUI [1,2])
C1880359 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1706080 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
C1706080 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0449788 (UMLS CUI [1,4])
C0332156 (UMLS CUI [1,5])
C1880359 (UMLS CUI [1,2])
C1706080 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
C0237753 (UMLS CUI [1,5])
C1706080 (UMLS CUI [1,2])
C0205436 (UMLS CUI [1,3])
C0449788 (UMLS CUI [1,4])
C0332156 (UMLS CUI [1,5])
C1290952 (UMLS CUI [1,2])
C1290952 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C1321605 (UMLS CUI-2)
C1880359 (UMLS CUI-3)
C1880359 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1706080 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
C1880359 (UMLS CUI [1,2])
C1706080 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,4])
C0449788 (UMLS CUI [1,5])
C1706080 (UMLS CUI [1,2])
C0205436 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
C1880359 (UMLS CUI [1,2])
C1706080 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
C0449788 (UMLS CUI [1,5])
Aucun commentaire